GlaxoSmithKline, Merck & Co., Inc., Sanofi-Aventis (France) Rotavirus Vaccines Save Poorest Children

August 6, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Reuters -- Trials in Asia and Africa show rotavirus vaccines can save the lives of even the poorest young children and programs should begin to vaccinate as many as possible, researchers reported on Thursday.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Postmarket research

Merck & Co. GlaxoSmithKline Sanofi (France)